Amphera is a late-stage biotechnology company developing cell therapies to treat cancer. MesoPher is comprised of autologous dendritic cells loaded with PheraLys, a lysate of tumour cell lines. PheraLys contains a broad repertoire of tumour-associated antigens, many of which are present in pancreatic cancer and other cancers.
Company Details
- Employees
- 4
- Founded
- -
- Address
- ’s-Hertogenbosch, Nl
- in****@****hera.nl
- Industry
- Biotechnology
- Website
- amphera.nl
- HQ
- ’s-Hertogenbosch
Amphera B.v. Questions
Amphera B.V.'s website is amphera.nl
Amphera B.V.'s LinkedIn profile is https://nl.linkedin.com/company/amphera
Amphera B.V. has
4 employees.
View email and phone details for 4
employees at Amphera B.V..
Amphera B.V.'s industry is
Biotechnology
Amphera B.V.'s top competitors are
Tagworks Pharmaceuticals,
Vectory,
Cimaas Bv,
Orca Therapeutics,
Targed Biopharmaceuticals,
Lava Therapeutics N.v.,
Oncolize,
Absano B.v.,
Enzytag Bv,
Ambagon Therapeutics.
Amphera B.V.'s support email address is info@amphera.nl
Amphera B.V.'s categories are Biotechnology
Amphera B.V.'s founding year is 2012
